|
|
|
| Antiviral Effect in Patients with Chronic Hepatitis C Treatedwith Peg-interferon α-2a Combined with Ribavirin |
| YAO Weimin, GUO Jianwen, CHEN Yan |
| The People's Hospital of Southern Medical University in Nanhai District, Guangdong Foshan 528200, China |
|
|
|
|
Abstract Objective: To observe the pathological changes of chronic hepatitis C after the treatment of peg-interferon α-2a combined with ribavirin. Methods: 40 patients with chronic hepatitis C visited our hospital from October 2014 to October 2015 as the research object, were randomly divided into two groups, 20 cases in each group. Observation group was treated with peg interferon α-2a and ribavirin, the control group was given general hepatoprotective treatment, The levels of ALT, HCVRNA and the pathological tissue of the two groups were compared. Results: After treatment, the observation group ALT recovery rate was 80%, there's no significant difference with the control group (P>0.05); the observation group HCVRNA negative rate was 90%, compared with the control group were significantly higher (P<0.05); liver inflammation and fibrosis of the observation group was significantly lower than before, and significantly lower than the control group (P<0.05). Conclusion: Antiviral treatment can significantly reduce the degree of liver inflammatory activity and fibrosis.It is of great significance to evaluate the effect of antiviral therapy from the pathological point.
|
|
|
| Fund:广东省佛山市医学类科技攻关项目,(编号:2014AB000262) |
|
|
|
[1] 中华医学会肝病学分会中华医学会传染病与寄生虫病学分会丙型肝炎防治指南[J].中华内科杂志,2004,43:551~555.
[2] 魏来,陈新月,窦晓光,张鸿飞,等.丙型肝炎临床诊断及治疗手册[M].北京:科学出版社,2012.
[3] 高得勇,张欣欣.丙型肝炎免疫发病机制的研究进展[J].国际流行病学传染病学杂志,2006,33(1):61~64.
[4] 王东生,姜艳芳,牛俊奇.丙型肝炎的免疫学研究进展[J].中国免疫学杂志,2010,26,(4):378~380,384.
[5] 周朝晖.干扰素利巴韦林联合胸腺素治疗慢性丙型肝炎疗效观察[J].肝脏,2008,13(1):96~97. |
|
|
|
2017, Vol. 23 
